Monthly Archives: September 2013

Report: Economic cost of flatlining HIV, TB, Malaria funds? Millions of lives, billions of dollars. Return on increased investments? Priceless . . .

By on .

Now is the time to step up investments, says report, which pegs costs of stalled HIV prevention at $47 billion, of undiagnosed TB at a million unnecessary deaths, and of malaria prevention and treatment failures at $20 billion lost productivity . . . Citing a need for an estimated $87 billion to countries eligible for […]

USAID brief on hormonal contraception: While questions remain, women at high risk and with HIV can use all available methods

By on .

While evidence of a tie between some injectable hormonal contraceptives and an increased risk of HIV acquisition remains incomplete, that potential risk must be balanced against the life-saving benefits of preventing unintended pregnancy, a brief from USAID’s Office of Population and Reproductive Health says. The brief, prepared in collaboration with the U.S. President’s Emergency Plan […]

As funding declines for nonprofit product development targeting global health concerns, innovation becomes key for financing

By on .

They target a seemingly diverse range of conditions — tuberculosis, HIV and malaria, along with illnesses long ignored outside of where their impact is felt — African trypanosomiasis, lieshmaniasis, Chagas disease — but they are linked by this: They are products without  profitable commercial markets in the places for which they are developed. For that […]

Falling short of the halfway mark, a cough not heard around the world, Uganda’s moral grounds, sex trafficking war casualties . . . We’re reading about global health winners, sinners, gains and losses

By on .

The Race to Improve Global Health: Great strides toward the halfway mark aren’t winning the race to a fair, healthy and sustainable world, says this New York Times editorial, a timely piece when  budget-weary policy makers might be tempted to rest on their achievements so far. United Nations’ Millenium Development Goals — including reductions in […]

Report, patent reform add signposts to intersection of health and human rights

By on .

“It is well understood,” this paper from Yale’s Global Health Justice Partnership begins, “that patent protection increases the price of medicines and thereby decreases access to them.” The result: The rich really are different. They can have more health. It is a truth, this paper points out, that runs counter to the right to health […]

Interactive experience walks users through HIV care continuum

By on .

You’re an adult female living in a country with a high HIV/AIDS prevalence.  One day a peer educator gives a presentation in your rural village on risk factors for HIV/AIDS and discusses HIV prevention methods.  You begin to worry you’re at risk because you regularly have unprotected sex with your male partner.  The peer educator […]

The Global Fund and U.S. direct assistance dominate global TB funding according to new report

By on .

According to “Mapping the Donor Landscape in Global Health: Tuberculosis”, another contribution to a series launched by the Kaiser Family Foundation, the Global Fund to Fight AIDS, Tuberculosis and Malaria and direct U.S. financing constitute 81 percent of global TB assistance and account for more than 75 percent of funding received in every region in […]

Report highlights global HIV donor landscape

By on .

It’s more important than ever for donors to coordinate on global investments towards achieving an AIDS-free generation, according to a report by the Kaiser Family Foundation, as part of an ongoing series of reports intended to shed light on the international donor landscape, as a tool for stakeholders in both donor and recipient countries. Global […]

Study finds medical circumcision scale up reduces HIV incidence in the community

By on .

The roll out of voluntary medical male circumcision (VMMC) programs in highly affected areas not only reduces HIV/AIDS acquisition among heterosexual men, but also significantly reduces HIV levels in the community, according to a study by researchers from the University of Versailles published in PLOS Medicine this week.  The study also found that VMMC is […]